Table 1 Clinical performance of " AccuPower SARS-CoV-2 Real Time RT-PCR kit " compared to "2019-nCoV CDC EUA kit". Value of 100% and 78.9% (95% CI: 65.98–91.9%) corresponds to specificity and sensitivity, respectively
From: Poor sensitivity of "AccuPower SARS-CoV-2 real time RT-PCR kit (Bioneer, South Korea)"
"AccuPower SARS-CoV-2" Positive | "AccuPower SARS-CoV-2" Negative | |
|---|---|---|
"2019-nCoV CDC" POSITIVE | 30 (78.9%) | 8 |
"2019-nCoV CDC" NEGATIVE | 0 | 10 (100%) |